We’re excited to share that Merck’s new monoclonal antibody, Enflonsia™, is now part of the CPP portfolio. This addition reflects the…
Merck
October 8, 2024
CPP Members, please keep an eye out for your CPP semi-annual rebate that will be coming by mail this month!…
February 19, 2024
Measles is on the rise across the world and country. As flu, COVID and RSV continue to be a concern,…